Skip to content skip to primary navi skip to secondary navi skip to meta navi search

Trials

The aims of the GHSG’s current trials are to further optimize first-line treatment in all stages of Hodgkin lymphoma and to improve therapy for relapsed patients, while minimizing treatment-related adverse effects and maintaining treatment efficacy.

Active trials

First-line treatment

Abbreviation Title Stage Trial design
EMBrACe EMBrACe – Patientenermächtigung durch Kompetenz: Über die Abwesenheit von Krebs hinaus Gesundheit erzielen. HL, alle Stadien Parallelgruppen Design, multizentrisch

Treatment of relapses

Abbreviation Title Stage Trial design